Depo-Medrol injectable suspension recalled for manufacturing temperature control deviations
McKesson Medical-Surgical is recalling Depo-Medrol (methylprednisolone acetate) 80mg/mL injectable suspension due to manufacturing temperature control deviations. The recall affects 177 cartons distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall with no reported illnesses or injuries. The hazard is a cGMP deviation (temperature abuse during manufacturing) that could affect product quality and stability, but no specific adverse events are documented. This is a precautionary recall of a manufacturing defect.
Plain-English summary
McKesson Medical-Surgical Inc. is recalling Depo-Medrol (methylprednisolone acetate) 80mg/mL injectable suspension in 1 mL single-dose vials and 25-count boxes (NDC 0009-3475-01 and 0009-3475-03) due to deviations from current Good Manufacturing Practice standards. The recall involves 177 cartons distributed nationwide.
The reason for the recall is temperature abuse during manufacturing. Temperature control is critical for ensuring the stability, potency, and sterility of injectable medications. McKesson Medical-Surgical states it is unable to identify which specific lot numbers were received by individual customers; however, recall notification letters have been sent to affected healthcare facilities with specific distribution dates and the range of dates when impacted product may have been shipped.
No illnesses or injuries have been reported in connection with this product. Patients currently using Depo-Medrol should contact their healthcare provider with any questions about their treatment. Healthcare facilities that received this product should check their records, quarantine affected product, and follow instructions provided in recall notification letters from McKesson.
The recalled product
- Product
- DEPO-MEDROL (METHYLPREDNISOLONE ACETATE)
- Brand
- DEPO-MEDROL
- Manufacturer
- Mckesson Medical-Surgical Inc. Corporate Office
- Category
- Drug — Injectable Corticosteroid
- Hazard
- temperature-abuse
- manufacturing-defect
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · DEPO-MEDROL
- HighFDA Recalls Depo-Medrol Injectable Due to Temperature Abuse in Manufacturing
FDA (Drugs) · 2022-06-15
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27